escitalopram/clonazepam

1
Reactions 1401 - 12 May 2012 Escitalopram/clonazepam Hypomania: 2 case reports Two patients developed hypomania while receiving escitalopram; clonazepam possibly contributed to hypomania in one of the patients [routes not stated]. A 40-year-old woman received escitalopram 10 mg/day, increased to 20 mg/day over 10 days, for recurrent depressive disorder. Over the next 4 weeks she became euthymic; however, after 3 months, she developed hypomania. She received valproate semisodium and olanzapine, and achieved remission within 4 weeks, which was maintained at last follow-up. A 67-year-old man received mirtazapine for depression; however, he did not improve after 15 days, and mirtazapine was gradually switched to escitalopram 10 mg/day. He also received clonazepam 0.5 mg/day at bed time to induce sleep. Over 4 weeks, his depressive symptoms resolved. After 3.5 months, he developed hypomania. He received quetiapine and valproate semisodium, which controlled his symptoms, and he was in remission at last follow-up. Author comment: "In the absence of any past or family history of suicide, depression, bipolar affective disorder in either case, hypomanic switch appears to be induced by escitalopram in both the cases. Except for a possibility of boosting the effect of escitalopram by clonazepam . . . in the induction of hypomania with escitalopram in the second case." Sharma RC. Hypomania induced by escitalopram: 2 case reports. Psychopharmacology Bulletin 42: 89-91, No. 2, 1 Jul 2009. Available from: URL: http://www.medworksmedia.com/IssueHome.aspx?id=1 - India 803069801 1 Reactions 12 May 2012 No. 1401 0114-9954/10/1401-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved

Upload: truongphuc

Post on 16-Mar-2017

215 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: Escitalopram/clonazepam

Reactions 1401 - 12 May 2012

Escitalopram/clonazepam

Hypomania: 2 case reportsTwo patients developed hypomania while receiving

escitalopram; clonazepam possibly contributed tohypomania in one of the patients [routes not stated].

A 40-year-old woman received escitalopram 10 mg/day,increased to 20 mg/day over 10 days, for recurrentdepressive disorder. Over the next 4 weeks she becameeuthymic; however, after 3 months, she developedhypomania. She received valproate semisodium andolanzapine, and achieved remission within 4 weeks, whichwas maintained at last follow-up.

A 67-year-old man received mirtazapine for depression;however, he did not improve after 15 days, and mirtazapinewas gradually switched to escitalopram 10 mg/day. He alsoreceived clonazepam 0.5 mg/day at bed time to inducesleep. Over 4 weeks, his depressive symptoms resolved.After 3.5 months, he developed hypomania. He receivedquetiapine and valproate semisodium, which controlled hissymptoms, and he was in remission at last follow-up.

Author comment: "In the absence of any past or familyhistory of suicide, depression, bipolar affective disorder ineither case, hypomanic switch appears to be induced byescitalopram in both the cases. Except for a possibility ofboosting the effect of escitalopram by clonazepam . . . in theinduction of hypomania with escitalopram in the secondcase."Sharma RC. Hypomania induced by escitalopram: 2 case reports.Psychopharmacology Bulletin 42: 89-91, No. 2, 1 Jul 2009. Available from: URL:http://www.medworksmedia.com/IssueHome.aspx?id=1 - India 803069801

1

Reactions 12 May 2012 No. 14010114-9954/10/1401-0001/$14.95 Adis © 2010 Springer International Publishing AG. All rights reserved